Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental modelSven A. Lang, Oliver Stoeltzing, Lee M. Ellis et al.|International Journal of Cancer|2007Cited by 167
Inhibition of heat shock protein 90 impairs epidermal growth factor–mediated signaling in gastric cancer cells and reduces tumor growth and vascularization <i>in vivo</i>Sven A. Lang, Oliver Stoeltzing|Molecular Cancer Therapeutics|2007Cited by 110
Inhibition of Heat Shock Protein 90 with AUY922 Represses Tumor Growth in a Transgenic Mouse Model of Islet Cell NeoplasmsVolker Fendrich, Sven A. Lang|Neuroendocrinology|2014Cited by 9